Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease

Haruhiko Ogata, Toshifumi Hibi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Endoscopic assessment of mucosal lesions has emerged as an important concept of disease activity in inflammatory bowel disease (IBD), and recently mucosal healing has been regarded as a therapeutic goal not only in ulcerative colitis (UC) but also in Crohn's disease (CD). Several evidences have now accumulated to show that mucosal healing determined by endoscopy can alter the course of IBD, as it is associated with sustained clinical remission, and reduced rates of hospitalization and surgical resection. Generally, clinical activity indices established in IBD are mainly determined based on subjective/objective signs and the results of laboratory tests. However, those indices sometimes lead to discrepancy compared with endoscopic indices. Although endoscopy has been rarely investigated as a predictor of the clinical course of IBD, there is now growing evidence that morphological examination, including endoscopy, may help to identify among IBD patients those who should be treated with more intensive treatments. Furthermore, as demonstrated in a recent study assessing early intervention with combination of biologics and immunomodulators, endoscopy may help to select patients who will get the best results upon early intervention. This chapter focuses on the assessment of endoscopic severity in UC and CD and on the impact of endoscopic severity on disease outcome. More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt therapeutic strategies.

Original languageEnglish
Title of host publicationCrohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach
PublisherSpringer US
Pages321-331
Number of pages11
ISBN (Print)9781461409984, 9781461409977
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Inflammatory Bowel Diseases
Endoscopy
Ulcerative Colitis
Crohn Disease
Immunologic Factors
Biological Products
Hospitalization
Therapeutics

Keywords

  • Activity indices
  • Crohn's disease
  • Endoscopy
  • Inflammatory bowel disease
  • Medical therapy
  • Mucosal healing
  • Surgery
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ogata, H., & Hibi, T. (2012). Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease. In Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach (pp. 321-331). Springer US. https://doi.org/10.1007/978-1-4614-0998-4_24

Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease. / Ogata, Haruhiko; Hibi, Toshifumi.

Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, 2012. p. 321-331.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ogata, H & Hibi, T 2012, Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease. in Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, pp. 321-331. https://doi.org/10.1007/978-1-4614-0998-4_24
Ogata H, Hibi T. Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease. In Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US. 2012. p. 321-331 https://doi.org/10.1007/978-1-4614-0998-4_24
Ogata, Haruhiko ; Hibi, Toshifumi. / Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Springer US, 2012. pp. 321-331
@inbook{759b3783a6644f75bbb5ee827994fefd,
title = "Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease",
abstract = "Endoscopic assessment of mucosal lesions has emerged as an important concept of disease activity in inflammatory bowel disease (IBD), and recently mucosal healing has been regarded as a therapeutic goal not only in ulcerative colitis (UC) but also in Crohn's disease (CD). Several evidences have now accumulated to show that mucosal healing determined by endoscopy can alter the course of IBD, as it is associated with sustained clinical remission, and reduced rates of hospitalization and surgical resection. Generally, clinical activity indices established in IBD are mainly determined based on subjective/objective signs and the results of laboratory tests. However, those indices sometimes lead to discrepancy compared with endoscopic indices. Although endoscopy has been rarely investigated as a predictor of the clinical course of IBD, there is now growing evidence that morphological examination, including endoscopy, may help to identify among IBD patients those who should be treated with more intensive treatments. Furthermore, as demonstrated in a recent study assessing early intervention with combination of biologics and immunomodulators, endoscopy may help to select patients who will get the best results upon early intervention. This chapter focuses on the assessment of endoscopic severity in UC and CD and on the impact of endoscopic severity on disease outcome. More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt therapeutic strategies.",
keywords = "Activity indices, Crohn's disease, Endoscopy, Inflammatory bowel disease, Medical therapy, Mucosal healing, Surgery, Ulcerative colitis",
author = "Haruhiko Ogata and Toshifumi Hibi",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-0998-4_24",
language = "English",
isbn = "9781461409984",
pages = "321--331",
booktitle = "Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach",
publisher = "Springer US",

}

TY - CHAP

T1 - Endoscopic assessment of disease activity and mucosal healing in inflammatory bowel disease

AU - Ogata, Haruhiko

AU - Hibi, Toshifumi

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Endoscopic assessment of mucosal lesions has emerged as an important concept of disease activity in inflammatory bowel disease (IBD), and recently mucosal healing has been regarded as a therapeutic goal not only in ulcerative colitis (UC) but also in Crohn's disease (CD). Several evidences have now accumulated to show that mucosal healing determined by endoscopy can alter the course of IBD, as it is associated with sustained clinical remission, and reduced rates of hospitalization and surgical resection. Generally, clinical activity indices established in IBD are mainly determined based on subjective/objective signs and the results of laboratory tests. However, those indices sometimes lead to discrepancy compared with endoscopic indices. Although endoscopy has been rarely investigated as a predictor of the clinical course of IBD, there is now growing evidence that morphological examination, including endoscopy, may help to identify among IBD patients those who should be treated with more intensive treatments. Furthermore, as demonstrated in a recent study assessing early intervention with combination of biologics and immunomodulators, endoscopy may help to select patients who will get the best results upon early intervention. This chapter focuses on the assessment of endoscopic severity in UC and CD and on the impact of endoscopic severity on disease outcome. More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt therapeutic strategies.

AB - Endoscopic assessment of mucosal lesions has emerged as an important concept of disease activity in inflammatory bowel disease (IBD), and recently mucosal healing has been regarded as a therapeutic goal not only in ulcerative colitis (UC) but also in Crohn's disease (CD). Several evidences have now accumulated to show that mucosal healing determined by endoscopy can alter the course of IBD, as it is associated with sustained clinical remission, and reduced rates of hospitalization and surgical resection. Generally, clinical activity indices established in IBD are mainly determined based on subjective/objective signs and the results of laboratory tests. However, those indices sometimes lead to discrepancy compared with endoscopic indices. Although endoscopy has been rarely investigated as a predictor of the clinical course of IBD, there is now growing evidence that morphological examination, including endoscopy, may help to identify among IBD patients those who should be treated with more intensive treatments. Furthermore, as demonstrated in a recent study assessing early intervention with combination of biologics and immunomodulators, endoscopy may help to select patients who will get the best results upon early intervention. This chapter focuses on the assessment of endoscopic severity in UC and CD and on the impact of endoscopic severity on disease outcome. More specifically, we discuss how endoscopy can be used at different stages of IBD to predict the disease course and/or to adapt therapeutic strategies.

KW - Activity indices

KW - Crohn's disease

KW - Endoscopy

KW - Inflammatory bowel disease

KW - Medical therapy

KW - Mucosal healing

KW - Surgery

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84955684906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955684906&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-0998-4_24

DO - 10.1007/978-1-4614-0998-4_24

M3 - Chapter

SN - 9781461409984

SN - 9781461409977

SP - 321

EP - 331

BT - Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach

PB - Springer US

ER -